APA (7th ed.) Citation

Reisinger, K. S., Block, S. L., Lazcano-Ponce, E., Samakoses, R., Esser, M. T., Erick, J., . . . Barr, E. (2007). Safety and persistent immunogenicity of a quadrivalent human papillomavirus types 6, 11, 16, 18 L1 virus-like particle vaccine in preadolescents and adolescents: A randomized controlled trial. The Pediatric infectious disease journal, 26(3), 201. https://doi.org/10.1097/01.inf.0000253970.29190.5a

Chicago Style (17th ed.) Citation

Reisinger, Keith S., et al. "Safety and Persistent Immunogenicity of a Quadrivalent Human Papillomavirus Types 6, 11, 16, 18 L1 Virus-like Particle Vaccine in Preadolescents and Adolescents: A Randomized Controlled Trial." The Pediatric Infectious Disease Journal 26, no. 3 (2007): 201. https://doi.org/10.1097/01.inf.0000253970.29190.5a.

MLA (9th ed.) Citation

Reisinger, Keith S., et al. "Safety and Persistent Immunogenicity of a Quadrivalent Human Papillomavirus Types 6, 11, 16, 18 L1 Virus-like Particle Vaccine in Preadolescents and Adolescents: A Randomized Controlled Trial." The Pediatric Infectious Disease Journal, vol. 26, no. 3, 2007, p. 201, https://doi.org/10.1097/01.inf.0000253970.29190.5a.